Anlotinib in patients with recurrent platinum-resistant or platinum-refractory ovarian carcinoma: A prospective, single-center, single-arm, phase II clinical trial (033)
Gynecologic Oncology（2022）
关键词
carcinoma,platinum-resistant,platinum-refractory,single-center,single-arm
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要